
==== Front
BMJ Open
BMJ Open
bmjopen
bmjopen
BMJ Open
2044-6055
BMJ Publishing Group BMA House, Tavistock Square, London, WC1H 9JR

10.1136/bmjopen-2024-085247
bmjopen-2024-085247
Original Research
Surgery
1737
1506
Consequences of delaying non-urgent surgeries during COVID-19: a population-based retrospective cohort study in Alberta, Canada
https://twitter.com/kharasauro
http://orcid.org/0000-0002-7658-4351
Sauro Khara 12kmsauro@ucalgary.ca

Vatanpour Shabnam 1shabnam.vatanpour1@ucalgary.ca

Thomas Abigail 2abigail.thomas2@ucalgary.ca

D'Souza Adam G 23adsouza@ucalgary.ca

Southern Danielle A 2dasouthe@ucalgary.ca

http://orcid.org/0000-0002-4569-8014
Eastwood Cathy 2caeastwo@ucalgary.ca

Ibadin Seremi 1seremi.ibadin1@ucalgary.ca

Ademola Ayoola 2ayoola.ademola@ucalgary.ca

Brindle Mary 2Mary.Brindle@albertahealthservices.ca

1 University of Calgary Cumming School of Medicine, Calgary, Alberta, Canada
2 Department Community Health Sciences, University of Calgary, Cumming School of Medicine, Calgary, Alberta, Canada
3 Alberta Health Services, Calgary, Alberta, Canada
Supplemental material This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.

None declared.

DrKharaSauro; kmsauro@ucalgary.ca
2024
31 8 2024
14 8 e08524721 2 2024
24 7 2024
Copyright © Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
2024
https://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.

Abstract

Objectives

To ensure sufficient resources to care for patients with COVID-19, healthcare systems delayed non-urgent surgeries to free capacity. This study explores the consequences of delaying non-urgent surgery on surgical care and healthcare resource use.

Design

This is a population-based retrospective cohort study.

Setting

This study took place in Alberta, Canada, from December 2018 to December 2021.

Participants

Adult patients scheduled for surgery in Alberta during the study period were included.

Primary and secondary outcomes measures

The proportion of surgeries completed and surgery wait time were the primary outcomes. The secondary outcomes were healthcare resource use (hospital length of stay, emergency room visits and physician visits). The association between the primary outcomes and patient and surgery-related variables was explored using regression.

Results

There were 202 470 unique patients with 259 677 scheduled surgeries included. Fewer surgeries were completed throughout the pandemic compared with before; in the fourth wave, there was a decrease from 79% pre-COVID-19 to 67%. There was a decrease in wait time for those who had surgery completed during COVID-19 (from 105 to 69 days). Having surgery completed and the wait for surgery were associated with the geographical zone, COVID-19 wave, and the surgery type and priority. There was a decrease in all measures of healthcare resource use and an increase in hospital and all-cause mortality during COVID-19 compared with before COVID-19.

Conclusions

The change in the proportion of scheduled surgeries completed and the wait time for completed surgery was modest and associated with COVID-19 wave and surgery-related variables, which was aligned with policies enacted during COVID-19 for surgery. The decrease in healthcare resource use suggests the effects of the COVID-19 pandemic may be delayed and may result in many patients presenting with advanced disease requiring surgical care.

SURGERY
COVID-19
Health policy
http://dx.doi.org/10.13039/501100000024 Canadian Institutes of Health Research 478240 The funders played no role in the data collection, analysis, or interpretation.
==== Body
pmcSTRENGTHS AND LIMITATIONS OF THIS STUDY

This study was population based and included all patients booked for surgery in a large province.

This study compared the year before COVID-19 to the first four waves of COVID-19.

It is likely that this study underestimates the number of patients whose access to surgical care was compromised due to the COVID-19 pandemic because we were only able to include patients who had a surgery scheduled and did not capture patients who were not able to be booked for surgery.

The generalisability of these findings should consider the context of the setting, including the number of COVID-19 cases, hospitalisations (including intensive care unit) and deaths; and policies about providing surgical care during the pandemic.

Introduction

The novel SARS-CoV-2 virus (COVID-19) was declared a pandemic in March 2020 by the WHO.1 The pandemic led to a large influx of patients with COVID-19 that required care in hospitals and intensive care units (ICUs). To accommodate this large number of patients with COVID-19, strategies were developed to create surge capacity within hospitals (ie, free up hospital and ICU beds and staff to care for COVID-19 patients), such as delaying or cancelling non-urgent surgeries (not immediately life-threatening).2 3 Due to the pandemic’s novel and rapidly evolving nature, these strategies were developed in the absence of high-quality evidence. Delaying non-urgent scheduled surgeries on the scale seen during COVID-19 is unprecedented; a modelling study estimates that globally there were over 28 million surgeries postponed during the peak of COVID-19 disruptions.4 The consequences of these decisions on patients and the healthcare system are only beginning to become evident. Evidence has outlined psychosocial impacts on patients (increased distress),5 and morbidity and mortality (patients waiting for surgery during COVID-19 were more than three times more likely to die than patients before COVID-19),6 and system-wide consequences of delayed surgery are emerging such as disruptions in cancer care (extended wait time for cancer surgery led to 843 years of life lost in one province and fewer detected cancers).7 8 Still, many studies continue to be small, single-centre studies or non-peer-reviewed reports.5914 While delaying non-urgent scheduled surgeries was likely necessary to redirect healthcare resources to the surges of COVID-19 patients, the effect of this on surgical care during COVID-19 or the impact of delaying surgeries on patients, healthcare providers and the system is unknown. Nor is there evidence to support strategies to mitigate the consequences of these decisions.

The objective of this study was to understand the number of surgeries delayed or cancelled during COVID-19 and explore the consequences of delaying non-urgent surgeries on patients and the healthcare system.

Methods

This study was conducted and reported in concordance with the Strengthening the Reporting of Observational Studies in Epidemiology and the Reporting of studies Conducted using Observational Routinely collected Data checklists.15 16

Study design and setting

This was a population-based retrospective cohort study conducted in Alberta, which has a population of 4.7 million.17 Healthcare is publicly funded, with tertiary healthcare services delivered by Alberta Health Services, the single health data custodian. At the time of analysis and writing, the majority of scheduled surgeries occur in the over 22 publicly funded adult acute care hospitals in the province. The province is divided into five geographical health regions (zones); North, Edmonton, Calgary, Central and South.

Participants (cohort)

Adult patients (18 years and older) scheduled for surgery between 1 December 2018 and 31 December 2021 were included. Patients were identified through a record in the Operating Room Information Systems (ORIS), a provincial surgical registry for all patients in Alberta.18 Patients are entered into the ORIS at the time they are consented for surgery. Patients who had data errors related to dates (eg, negative wait time or scheduled surgery date before decision to treat date), whose surgery date or last transaction date was outside of the study period, or whose surgery date was the same date as an emergency department visit date (ie, likely an urgent surgery) were excluded (online supplemental file 1).

Data sources, access, linkage and cleaning

The cohort was identified using ORIS and encounter-level data were deterministically linked to four data sources to obtain information about hospital stays, emergency room visits, physician visits and mortality using a unique provincial healthcare number (PHN). The Discharge Abstract Database (DAD) includes demographic, administrative, diagnostic and procedural data on all patients discharged from the hospital.1921 The National Ambulatory Care Recording System (NACRS) collects demographic, administrative, clinical and service-specific data from hospital-based and community-based ambulatory care visits, including day surgery, community outpatient clinic and emergency department visits.2224 Physician billing claims are used to bill the province of Alberta for physician services provided. Vital statistics include information about the date and cause of death.

These data sources were retrospectively abstracted in May 2022 by the data custodian (Alberta Health Services). Deidentified data (scrambled PHN) were provided to the principal investigator (KS). The range of data values, distribution and missing values were explored for all variables and data cleaning was performed by a trained data analyst (SV). A data enhancement strategy was used to deal with missing values.25

Outcomes & Variables

The primary outcomes were the proportion of surgeries completed and the wait time for surgery. Surgery status was a categorical variable with three levels—completed, waiting and cancelled reported in ORIS. The proportion of surgeries completed was the number of completed surgeries over the number of scheduled surgeries. Correspondingly, the proportion of surgeries cancelled or waiting was calculated as the number of surgeries cancelled or waiting over the number of scheduled surgeries.

For those who had surgery completed, the wait time was calculated as the difference between the date of surgery and the last ready-to-treat day (the date which was mutually agreeable to the patient and surgeon) in days. While the time from booking date to surgery date was available, we chose to include the last ready-to-treat date to take into considerations the wait time that was not due to healthcare system delays.

The secondary outcomes were healthcare resource use. In the absence of a single measure of healthcare resource use, cumulative length of hospital stay (total hospital length of stay for every hospital admission from DAD), the number of hospital readmissions (DAD), the number of emergency room visits (NACRS) and the number of physician visits (physician claims) were used to measure healthcare resource use.

Patient and surgery-related variables included patient age, sex, comorbidities (Charlson Comorbidity Index) and geographical zone at index surgery were abstracted from DAD, physician claims and ORIS. Patient’s age and sex were obtained from ORIS. Comorbidities were calculated based on ICD-10-CA (International Classification of Disease, 10th Edition, Canada) codes in the DAD and ICD-9-CA codes in the physician claims database and were calculated using the Quan method.26

Surgical variables included the type of surgery (categorical variable in ORIS), cancer-related surgeries (dichotomous variables in ORIS), priority level (categorical variables in ORIS), and if COVID-19 was the reason for a change to the surgery date (string variable in ORIS). The type of surgery was determined by the most responsible healthcare provider and recorded in ORIS and was classified as cardiovascular, dentistry, gastrointestinal, general, neurology, obstetrics/gynaecology, ophthalmology, oral and maxillofacial, orthopaedic, otolaryngology, plastic, thoracic, transplant, urology, vascular and other. The recommended wait time was calculated using the Alberta Coding Access Targets for Surgery codes,27 developed based on evidence-based best-practice guidelines for surgical care, to determine the priority for each surgery which was categorised as urgent priority (0–2 weeks), high priority (3–6 weeks), moderate priority (7–12 weeks) and lower priority (13+ weeks).

Time periods were created to explore the effects of the unique ‘waves’ of COVID-19 since there were strategic changes to surgical care during the study period. The time periods were defined as pre-COVID-19 (1 January 2018–29 February 2020), wave 1 (1 March 2020–22 August 2020), wave 2 (23 August 2020–20 March 2021), wave 3 (21 March 2021–17 July 2021), wave 4 (18 July 2021–31 December 2021). Surgeries were classified by the time period (wave) according to when they were booked for surgery.

Data analysis

The demographic characteristics of the cohorts were described using proportions, means (SD) and medians (IQR). One-way analysis of variance (ANOVA) for continuous variables, Kruskal-Wallis tests for skewed continuous variables and χ2 tests for categorical variables were used to assess differences in the demographic characteristics, healthcare resource utilisation and safety pre-COVID-19 and across COVID-19 waves.

To examine the effect that patient characteristics had on the primary outcomes (surgery completed and wait time), regression models were used. Multivariable logistic regression was used to examine the effect of potential factors on having surgery completed during each wave of the COVID-19 pandemic (dichotomous; completed vs not completed) while multivariable quantile regression was used to identify factors associated with surgery wait time (continuous variable). Variable clustering was used for assessing collinearity and redundancy of candidate variables. Potential effect measure modifiers, confounder or predictor variables included patient sex, age, cancer status (cancer-related vs non-cancer-related surgeries), Charlson Comorbidity Index and type of surgeries. Potential interaction terms were included in the regression models to evaluate effect modification, and the models were adjusted for confounders. In addition, all potential interactions and confounders were extensively explored through data inspection (online supplemental file 1). Coefficients or ORs are presented with 95% CIs and are unadjusted unless indicated, and ANOVA plot was used to identify the largest effect size for each outcome.

All statistical analyses were conducted by using R software (V.4.2.3), and R packages rms28 and ggplot2.29

Patient and public involvement

Patients and the public were not involved in the conception of this study, nor were they involved in data collection, analysis or interpretation of the findings.

Results

Characteristics of the cohort

There were 202 470 unique patients with 259 677 scheduled surgeries (online supplemental file 2). The median age of patients was 59 years old, with the majority being female (55.5%, n=144 237), having surgery in the Edmonton zone (30.9%, n=80 215; table 1). The type of surgeries that were scheduled differed between the time periods; overall the most common type of surgery was general surgeries (25.7%, n=668 222), orthopaedic (19.7%, n=51 134) and ophthalmologic (16.5%, n=42 897) with the number of ophthalmological surgeries decreased during COVID-19 to 10.7% (n=3075) of surgeries (table 1). Similarly, the number of scheduled cancer surgeries increased from 10.4% (n=19 835) to 16.7% in the fourth wave of COVID-19 (n=4788, table 1).

Table 1 Characteristics of the cohort

Variable	Cohort	Pre-COVID-19	Wave1	Wave2	Wave3	Wave4	P value	
Scheduled surgeries	259 677	115 537	33 648	52 580	29 229	28 683	<0.001	
Sex male (%)	115 440 (44.5)	50 532 (43.7)	15 276 (45.4)	23 702 (45.1)	12 969 (44.4)	12 961 (45.2)	<0.001	
Age	
 Median (IQR)	59.0(43.0–70.0)	58.0(43.0–70.0)	59.0(43.0–70.0)	59.0(43.0–70.0)	58.0(43.0–69.0)	58.0(43.0–69.0)	0.001	
 Mean (SD)	56.23 (17.0)	56.25 (17.1)	56.31 (17.0)	56.33 (17.0)	56.14 (16.9)	55.90 (16.8)	0.007	
Comorbidities*	
 Mean (SD)	0.51 (1.4)	0.53 (1.4)	0.55 (1.4)	0.49 (1.3)	0.48 (1.3)	0.45 (1.3)	<0.001	
 0	211 447 (81.4)	93 961 (81.3)	27 040 (80.4)	42 805 (81.4)	23 928 (81.9)	23 713 (82.7)	<0.001	
 1	15 794 (6.1)	7126 (6.2)	2163 (6.4)	3305 (6.3)	1689 (5.8)	1511 (5.3)		
 2+	32 436 (12.5)	14 450 (12.5)	4445 (13.2)	6470 (12.3)	3612 (12.4)	3459 (12.1)		
Surgery type	<0.001	
 Cardiovascular	4185 (1.6)	1144 (1.0)	758 (2.3)	973 (1.9)	593 (2.0)	717 (2.5)		
 Dentistry	647 (0.2)	351 (0.3)	76 (0.2)	114 (0.2)	57 (0.2)	49 (0.2)		
 Gastrointestinal	892 (0.3)	387 (0.3)	468 (1.4)	37 (0.1)	0 (0.0)	0 (0.0)		
 General	668 222 (25.7)	28 440 (24.6)	8675 (25.8)	13 591 (25.8)	7819 (26.8)	8297 (28.9)		
 Neurology	4075 (1.6)	1753 (1.5)	524 (1.6)	774 (1.5)	509 (1.7)	515 (1.8)		
 Obstetrics/gynaecology	35 556 (13.7)	16 008 (13.9)	4382 (13.0)	6848 (13.0)	4071 (13.9)	4247 (14.8)		
 Ophthalmology	42 897 (16.5)	21 327 (18.5)	5255 (15.6)	8989 (17.1)	4251 (14.5)	3075 (10.7)		
 Oral and maxillofacial	422 (0.2)	217 (0.2)	45 (0.1)	81 (0.2)	48 (0.2)	31 (0.1)		
 Orthopaedic	51 134 (19.7)	22 316 (19.3)	6445 (19.2)	10 647 (20.2)	6024 (20.6)	5702 (19.9)		
 Other	202 (0.1)	8 (0.0)	8 (0.0)	29 (0.1)	41 (0.1)	116 (0.4)		
 Otolaryngology	12 934 (5.0)	5922 (5.1)	1531 (4.6)	2515 (4.8)	1397 (4.8)	1569 (5.5)		
 Plastics	12 576 (4.8)	5924 (5.1)	1684 (5.0)	2421 (4.6)	1385 (4.7)	1162 (4.1)		
 Thoracic	815 (0.3)	362 (0.3)	112 (0.3)	174 (0.3)	69 (0.2)	98 (0.3)		
 Transplant	295 (0.1)	110 (0.1)	40 (0.1)	55 (0.1)	31 (0.1)	59 (0.2)		
 Urology	24 430 (9.4)	10 402 (9.0)	3436 (10.2)	4967 (9.4)	2754 (9.4)	2871 (10.0)		
 Vascular	1795 (0.7)	866 (0.7)	209 (0.6)	365 (0.7)	180 (0.6)	175 (0.6)		
 Cancer surgery	31 501 (12.1)	12 017 (10.4)	4327 (12.9)	6357 (12.1)	4012 (13.7)	4788 (16.7)	<0.001	
Zone (%)	<0.001	
 Calgary	41 262 (15.9)	19 835 (17.2)	4681 (13.9)	7334 (13.9)	4985 (17.1)	4427 (15.4)		
 Central	71 546 (27.6)	31 493 (27.3)	9407 (28.0)	15 130 (28.8)	8003 (27.4)	7513 (26.2)		
 Edmonton	80 215 (30.9)	35 070 (30.4)	11 180 (33.2)	16 013 (30.5)	8482 (29.0)	9470 (33.0)		
 North	28 991 (11.2)	12 274 (10.6)	3637 (10.8)	6486 (12.3)	3484 (11.9)	3110 (10.8)		
 South	37 663 (14.5)	16 865 (14.6)	4743 (14.1)	7617 (14.5)	4275 (14.6)	4163 (14.5)		
Pre-COVID-19 (1 January 1, 2018 –29 February 29, 2020), wave 1 (1 March 1, 2020 –22 August 22, 2020), wave 2 (23 August 23, 2020 –20 March 20, 2021), wave 3 (21 March 21, 2021 –17 July 17, 2021), wave 4 (18 July 18, 2021–31 December 31, 2021).

* Charlson Comorbidity Index calculated using all records.

n, number

Surgery status

Overall, 77.4% (n=201 061) of scheduled surgeries were completed in the cohort, 17.6% (n=45 591) were cancelled and 5.0% (n=13 025) were waiting (figure 1). The proportion of scheduled surgeries completed, cancelled and waiting changed throughout the COVID-19 pandemic (p<0.001). The proportion of surgeries that were completed remained stable until wave 4, where the proportion decreased to 67.0%. The number of surgeries that were waiting increased throughout the pandemic with a sharp increase in wave 4 to 17.1% (n=4902), and the number of surgeries cancelled remained stable except with a decrease (fewer surgeries cancelled) in wave 3 before returning to pre-COVID-19 levels in wave 4 (figure 1). Using logistic regression, geographical zone where the surgery was scheduled, the COVID-19 wave, the type of surgery, the priority level, whether it was a cancer surgery, patient age, sex and comorbidity were all associated with the surgery being completed. Patients who had lower priority dental or oral/maxillofacial surgery, scheduled in the two largest urban geographical zones, who were older with multimorbidity in wave 4 of COVID-19 had the lowest odds of having their surgery completed (online supplemental file 3). Using ANOVA, the priority level, type of surgery and geographical zone had the largest effect size (online supplemental file 3). When controlling for age, sex, geographical zone, cancer-related surgery and surgery type, the odds of having a surgery completed in wave 1 was 1.12 (95% CI 1.08 to 1.16), in wave 2 was 1.37 (95% CI 1.31 to 1.44), in wave 3 was 1.39 (95% CI 1.30 to 1.49), and in wave 4 was 1.03 (95% CI 0.94 to 1.12) compared with pre-COVID-19.

Figure 1 Surgery status by COVID-19 wave. ICU, intensive care unit.

Wait time for surgery

For completed surgeries, the median wait time decreased from before COVID-19 across each COVID-19 wave (figure 2). The factors associated with the wait time were geographical zone, COVID-19 wave and the surgery type and priority (online supplemental file 3). Those who had their surgery in geographical zones outside the two major cities, who had a transplant, cardiovascular/vascular/thoracic surgery and were deemed a high priority had shorter wait times (online supplemental file 4). Using ANOVA, the priority level, type of surgery and geographical zone had the largest effect size (online supplemental file 4).

Figure 2 Median wait time by surgery and COVID-19 wave. Time periods are recommended time for type of surgery (0-2 weeks, 3-6 weeks, 7-12 weeks, 13+ weeks).

The median wait time for scheduled surgery varied between the types of surgeries; ophthalmologic, oral and maxillofacial (and dentistry), and orthopaedic surgeries consistently had longer wait times but consistently decreased across COVID-19 waves (p<0.0001; figure 2). Wait time for cancer surgery remained relatively unchanged across time periods, with a small decrease in wait time during wave 1 compared with the other time periods (pre-COVID-19: median=5.71 weeks, IQR=3.14–11.85, wave 1: median=4.71 weeks, IQR=2.43–11.43, wave 2: median=5.15 weeks, IQR=2.86–10.29, wave 3: 5.43 weeks, IQR=3.00–11.4, wave 4: 5.29 weeks, IQR=2.72–10.86; p<0.0001). The median surgery wait time for higher-priority surgeries was relatively unchanged, and the wait time for lower-priority surgeries decreased across COVID-19 waves (p<0.001).

When controlling for age, sex, geographical zone, cancer-related surgery and surgery type the geometric mean wait time in wave 1 was reduced by 5.8% (95% CI −7.4% to −4.2%), in wave 2 was reduced by 16.9% (95% CI −20.0% to −14.9%), in wave 3 was reduced by 18.8% (95% CI −21.8% to −15.9%), and in wave 4 was reduced by 22.1% (95% CI −25.8% to −18.4%) compared with the geometric mean wait time pre-COVID-19.

When examining surgeries that specifically were delayed due to COVID-19-related capacity issues, the median surgery wait time increased from 19.85 (IQR=10.82–38.43) weeks in wave 1 to 34.57 weeks (IQR=14.57–50.29) in wave 2, before decreasing to 28.29 (IQR=21.86–36.29) weeks in wave 3 and to 14.29 (IQR=9.29–21.29) weeks in wave 4 (p<0.001) for surgeries that were delayed due to COVID-19.

Healthcare resource use

Among patients scheduled for surgery, there were 155 687 hospital admissions among 113 023 unique patients during the study period, with the number of scheduled surgeries requiring hospital admission being lower before COVID-19 than during each wave of COVID-19 (table 2). However, the number of hospital admissions per patient admitted was lower during each wave of COVID-19 than before COVID-19 (table 2). While in the hospital, the number of ICU hours and, correspondingly, the resource intensity of patients was lower during all waves of COVID-19 than before COVID-19. The number of patients with an index hospital admission who was readmitted within 30 days was similar before COVID-19 and across all waves of COVID-19. The number of emergency room visits was similar across all waves of COVID-19 but was lower than before COVID-19. A similar pattern emerged when examining the number of physician visits; the number of physician visits per patient was similar across each wave of COVID-19 but went from 14.0 (IQR=8.00–23.00) before COVID-19 to 5.00 (3.00–10.00) in wave 1, 7.00 (IQR=4.00–13.00) in wave 2, 4.00 (IQR=2.00–8.00) in wave 3 and 5.00 (IQR=3.00–10.00) in wave 4.

Table 2 Healthcare resource use

Variable	Pre-COVID-19	Wave 1	Wave 2	Wave 3	Wave 4	P value	
Crude	Adj*	Crude	Adj*	Crude	Adj*	Crude	Adj*	Crude	Adj*	Crude	
Hospital visits†n (%)	61 089(38.83)	123 785 (76.58)	23 733(54.65)	33 265 (76.60)	31 290(44.74)	53 956 (77.00)	18 840(51.47)	28 477 (77.85)	20 735(55.15)	29 013 (77.17)		
Hospital visits per patientMean (SD)	1.52 (1.07)	1.47 (1.07)	1.29 (0.70)	1.41 (0.51)	1.33 (0.76)	1.35 (0.56)	1.25 (0.62)	129 (0.60)	1.31 (0.72)	1.24 (0.81)	<0.001	
Hospital length of stay (days)‡Median (IQR)§	26.00(10.00–60.00)	10.18 (0.14)	14.00(6.00–36.00)	12.26 (0.21)	19.00(7.00–45.00)	11.53 (0.19)	12.00(5.00–33.00)	12.65 (0.24)	15.00(6.00–32.00)	12.86 (0.23)	<0.001	
Resource intensityMedian (IQR)	1.95 (1.09–3.60)	1.42 (0.01)	1.69 (0.98–3.21)	1.71 (0.01)	1.77 (1.04–3.41)	1.66 (0.01)	1.71 (0.92–3.30)	1.78 (0.01)	1.78 (1.02–3.30)	1.74 (0.01)	<0.001	
ICU (hours)‡Median (IQR)§	54.30(8.20–127.10)	11.42 (0.41)	19.30(0.00–70.70)	13.97 (0.60)	23.60(0.00–91.65)	13.03 (0.53)	17.70(0.00–68.50)	14.41 (0.66)	20.40(0.00–80.35)	14.12 (0.66)	<0.001	
Hospital readmission(30 days)Mean (SD)	528 (1.3)	563 (1.4)	309 (1.7)	257 (1.4)	300 (1.3)	306 (1.3)	219 (1.5)	211 (1.4)	201 (1.3)	221 (1.4)	<0.001	
Emergency visits Total	231 674	229 357	75 244	74 491	93 419	92 484	57 661	57 084	74 187	73 445		
Emergency visitsMedian (IQR)¶	2.00(1.00–3.00)	2.00	1.00(1.00–2.00)	1.00	1.00(1.00–2.00)	1.00	1.00(1.00–2.00)	1.00	1.00(1.00–2.00)	1.00	<0.001	
* Adjusted for age at surgical admission, biological sex, Charlson Comorbidity Index, surgery type.

† Proportion of visits per scheduled surgeries.

‡ Cumulative length of stay.

§ Adjusted estimates include SD based on regression model.

¶ Variance too low to report.

Adj, adjusted

Mortality

The number of patients who died while in hospital increased during COVID-19 compared with before COVID-19, with the highest proportion of hospital admissions resulting in death being in wave 4 (0.5% of hospital admissions died before COVID-19, 1.4% in wave 1, 1.8% in wave 2, 1.9% in wave 3 and 3.2% in wave 4, p<0.001). Overall all-cause mortality among patients scheduled for surgery also increased to 5.85% in wave 4 compared with 0.93% before COVID-19 (wave 1=2.74%, wave 2=2.96% and wave 3=3.26%).

Discussion

In this study, while a larger proportion of scheduled surgeries were cancelled during many of the waves of COVID-19, the proportion of scheduled surgeries completed remained relatively stable until the fourth wave of COVID-19. The priority level of the surgery and the geographical zone were two of the strongest predictors of surgeries being completed, suggesting that COVID-19-related factors significantly contributed to surgeries being completed during COVID-19 and that some jurisdictions were more impacted than others, consistent with provincial trends in COVID-19 cases and hospitalisation.30 For completed surgeries, the wait time decreased during COVID-19 and was associated with the priority level of the surgery, the type of surgery and the geographical zone where the surgery was scheduled. This finding is aligned with policies for surgical prioritisation during COVID-19 that outlined only high-priority surgeries, including cancer surgeries, were scheduled during some waves of COVID-19,31 resulting in fewer surgeries of lower priority being scheduled, consequently reducing wait for surgery. Similarly, there was decreased healthcare resource use during COVID-19 and increased mortality.

During COVID-19, policies were enacted that prioritised cancer surgeries and high-priority surgeries among acutely ill patients.31 These policies may have been drivers of surgeries being completed; COVID-19 wave, which may be a surrogate measure of surgical policies was one of the strongest predictors of wait times. These findings speak to the important role policy has in healthcare delivery. While this study was not designed to evaluate the effectiveness of policies for surgery during COVID-19, the findings suggest that policies that prioritised cancer surgery and other specific types of surgeries3 resulted in more surgeries being completed and within clinically appropriate wait times. Additional research is needed to explore the appropriateness and effectiveness of policies for surgery during COVID-19. During COVID-19, many policies were implemented with little supporting evidence due to the novel nature of COVID-19 and the rapidly evolving situation; however, even outside of the pandemic, policies are not always evidence informed.32 33 Incorporating evidence into health policy is critical and requires two key elements—having high-quality evidence to inform policy and approaches for incorporating evidence into policy. The growing body of evidence on surgical care during healthcare crises, generated since the beginning of the COVID-19 pandemic, can be used to inform surgical policies moving forward.10 12 34 35 Strategies to strengthen evidence-informed health policy include better collaboration between health researchers and policy-makers; these symbiotic relationships and collaborative strategies should be established now so that during times of healthcare crisis urgent policies can be enacted.36

An important evidence-based consideration when developing policies to manage surgical wait times is the effect delays in surgery have on clinical outcomes. Delays in having non-urgent surgeries within clinically appropriate time frames are associated with increases in undesirable outcomes, including mortality.37 38 Indeed, we and others found that during COVID-19, there was an excess death rate (more observed deaths than expected) not attributed to COVID-19.39 40 Some of these excess deaths may be partly attributable to delayed surgeries,41 including those waiting to be scheduled for surgery which was not accounted for in this study resulting in an underestimate of the impact on patient health. Understanding the complex relationship between increased mortality and surgical delays was beyond the scope of this study. The impact of delaying non-urgent surgeries likely goes beyond mortality to patient quality of life, disease-specific outcomes, healthcare provider work satisfaction and wellness, and the healthcare system, as has been found during non-pandemic times.134248 Studies from our group found that patients and surgeons experienced many negative consequences related to delaying non-urgent surgeries during COVID-19.5 49 Patients experienced a decrease in quality of life and included considerable distress while waiting for surgery during an uncertain time. Surgeons also experienced a great deal of distress, especially related to not being able to care for their patients to the best of their abilities but provided strategies to minimise the impact of caring for patients during times of healthcare constraint which should be considered.49 These findings may extend beyond the pandemic as waiting for surgery persists.5 Times of healthcare constraints continue in Canada and across the globe during the recovery from the wider impacts of COVID-19; future research is needed to understand the complex relationship between waiting longer than clinically recommended for surgery and outcomes beyond just survival and developing strategies to minimise the burden on patients, their healthcare providers and healthcare systems.

Access to healthcare is an important factor in wait times for surgery. The decrease in all measures of healthcare resource use suggests a decrease in access to healthcare, which has been corroborated by others.50 It has been reported that patients avoided accessing the healthcare system because of a decrease in available health services, isolation measures and fear of contracting COVID-19.51 52 The consequence of the decrease in healthcare resource use, including diagnostic services, may result in an impending surge in patients being diagnosed with illnesses such as cancer, consequently, there may be a surge in patients requiring surgical treatment for these illnesses.8 53 Studies also suggest that this decrease in healthcare resource use will result in patients being diagnosed with more advanced disease states requiring more complex and invasive treatment.54 55 The implications of the COVID-19 pandemic on the healthcare system and healthcare resource use will likely not be clear for some time. Continued epidemiological surveillance of disease and health services research into the evolving trends in healthcare resource use are needed to meet the healthcare needs of the population.

While this study has several strengths; population-based data across 3 years covering 1 year prior to COVID-19 and the four largest waves of COVID-19, limitations should be noted and considered. While our surgery data (ORIS) were rich and had many time-related variables, these data are not intended for research purposes and, therefore, are not regularly monitored for quality on a regular basis; indeed, there were some data entry errors noted and there were some missing dates which we were able to impute using variables in the other data sources (see figure 1). Additionally, exploring effect modifiers and confounders identified that surgery type was an effect measure modifier, however, due to the large number of categories and small sample sizes in some cells we were not able to present the stratified estimates in the main body of the paper for all effect measure modifiers; more research is needed to explore within surgery variance in more detail, as the type of surgery was an important factor in having surgery completed and the wait time for surgery. The present study likely underestimates the number of patients whose access to surgical care was compromised due to the COVID-19 pandemic because we were only able to include patients who had a surgery scheduled (entered into ORIS), which excludes a group of patients waiting for a referral to a surgeon. Similarly, with reduced operating room availability, surgeons were not able to schedule patients they knew required surgery. On a related note, we chose to use the time from the last ready-to-treat date to surgery date (wait 2) rather than time from booking to surgery which may have also underestimated the wait time to surgery. While leveraging routinely collected administrative health data was efficient, we could not measure outcomes related to quality of life and patient and healthcare provider experiences. However, our previous studies provide insight into the patient and healthcare provider experience during COVID-19.5 Finally, generalisability of these findings beyond Alberta should be cautioned and factors such as a number of COVID-19 cases, hospitalisations and COVID-19-related public health measures including surgical policies should be considered when generalising these findings to other areas.

In conclusion, this study found modest changes in the proportion of surgeries completed throughout the first four waves of COVID-19 but no increase in wait times for completed surgeries. However, this should be interpreted with caution. Interestingly, there was a decrease in healthcare resource use and an increase in mortality during COVID-19. This suggests during times of healthcare constraint, patients may avoid seeking the healthcare they need, resulting in an increase in mortality, which may extend beyond the COVID-19 pandemic to times of healthcare constraint. Notably, the factors associated with having surgeries completed and waiting for surgery (COVID-19 wave, geographical location, surgery type and priority) are aligned with policies enacted during COVID-19 to prioritise surgical care for those with cancer or high-priority surgeries; future research should explore the effectiveness of these policies. This highlights the important role health policy plays in healthcare delivery and the need for evidence-informed policy through collaboration.

supplementary material

10.1136/bmjopen-2024-085247 online supplemental file 1

10.1136/bmjopen-2024-085247 online supplemental file 2

10.1136/bmjopen-2024-085247 online supplemental file 3

10.1136/bmjopen-2024-085247 online supplemental file 4

10.1136/bmjopen-2024-085247 online supplemental file 5

Data availability statement

Data are available on reasonable request.

Review Process File
31 08 2024

Funding: This study was funded through a Canadian Institutes of Health Research grant awarded to Khara Sauro (Wider Impacts of COVID-19 grant # 478240).

Prepublication history and additional supplemental material for this paper are available online. To view these files, please visit the journal online (https://doi.org/10.1136/bmjopen-2024-085247).

Provenance and peer review: Not commissioned; externally peer reviewed.

Patient consent for publication: Not applicable.

Data availability free text: Data will be made available on reasonable request to the corresponding author.

Patient and public involvement: Patients and/or the public were not involved in the design, or conduct, or reporting, or dissemination plans of this research.

Ethics approval: This study was approved by the University of Calgary Health Research Ethics Board (REB20-0753). A waiver of consent was granted for this study.
==== Refs
References

1 World Health Organization Available https://covid19.who.int/?gclid=EAIaIQobChMIt5Xu74WC7AIV3z2tBh2KngctEAAYASAAEgIRV_D_BwE
2 Prin M Guglielminotti J Mtalimanja O et al Emergency-to-elective surgery ratio: a global indicator of access to surgical care World J Surg 2018 42 1971 80 10.1007/s00268-017-4415-7 29270649
3 Ibadin S Brindle M Wasylak T et al Delivery and prioritization of surgical care in Canada during COVID-19: an environmental scan Int J Health Policy Manag 2023 12 8007 10.34172/ijhpm.2023.8007 38618771
4 COVIDSurg Collaborative Elective surgery cancellations due to the COVID-19 pandemic: global predictive modelling to inform surgical recovery plans Br J Surg 2020 107 1440 9 10.1002/bjs.11746 32395848
5 Sauro KM Smith C Kersen J et al The impact of delaying surgery during the COVID-19 pandemic in Alberta: a qualitative study CMAJ Open 2023 11 E90 100 10.9778/cmajo.20210330
6 Ciarleglio FA Rigoni M Mereu L et al The negative effects of COVID-19 and national lockdown on emergency surgery morbidity due to delayed access World J Emerg Surg 2021 16 37 10.1186/s13017-021-00382-z 34256781
7 Parmar A Eskander A Sander B et al Impact of cancer surgery slowdowns on patient survival during the COVID-19 pandemic: a microsimulation modelling study CMAJ 2022 194 E408 14 10.1503/cmaj.202380 35314440
8 Eskander A Li Q Yu J et al Incident cancer detection during the COVID-19 pandemic J Natl Compr Canc Netw 2022 20 276 84 10.6004/jnccn.2021.7114 35104788
9 Canadian Institute for Health Information CIHI’s COVID-19 data and information Ottawa, ON Canadian Institute for Health Information
10 O’Rielly CM Ng-Kamstra J Kania-Richmond A et al Surgery & COVID-19: a rapid scoping review of the impact of COVID-19 on surgical services during public health emergencies BMJ Open 2021 1 e043966 10.1136/bmjopen-2020-043966
11 Eskander A Li Q Hallet J et al Access to cancer surgery in a universal health care system during the COVID-19 pandemic JAMA Netw Open 2021 4 e211104 10.1001/jamanetworkopen.2021.1104 33704472
12 Wang J Vahid S Eberg M et al Clearing the surgical backlog caused by COVID-19 in Ontario: a time series modelling study CMAJ 2020 192 E1347 56 10.1503/cmaj.201521 32873541
13 Forner D Murnaghan S Porter G et al Psychosocial distress in adult patients awaiting cancer surgery during the COVID-19 pandemic Curr Oncol 2021 28 1867 78 10.3390/curroncol28030173 34068441
14 Canadian Institute for Health Information Surgeries impacted by COVID-19: an update on volumes and wait times
15 Elm E von Altman DG Egger M et al Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies BMJ 2007 335 806 8 10.1136/bmj.39335.541782.AD 17947786
16 Benchimol EI Smeeth L Guttmann A et al The REporting of studies conducted using observational routinely-collected health data (RECORD) statement PLOS Med 2015 12 e1001885 10.1371/journal.pmed.1001885 26440803
17 Population statistics Available https://www.alberta.ca/population-statistics.aspx#population-estimates accessed 5-Jul-2023
18 Segall RE Takata JL Urbach DR Wait-time reporting systems for elective surgery in Canada: a content analysis of provincial and territorial initiatives CMAJ Open 2020 8 E844 51 10.9778/cmajo.20200033
19 Canadian Institute for Health Information Data quality documentation, discharge abstract database — current-year information, 2020–2021 2021
20 Canadian Institute for Health Information DAD data elements 2021–2022 2021
21 Canadian Institute for Health Information DAD abstracting manual 2021
22 Canadian Institute for Health Information Data quality documentation, national ambulatory care reporting system — multi-year information 2012
23 Canadian Institute for Health Information NACRS data elements 2021–2022 2021
24 Canadian Institute for Health Information NACRS abstracting manual, 2021–2022 2021
25 Faris PD Ghali WA Brant R et al Multiple imputation versus data enhancement for dealing with missing data in observational health care outcome analyses J Clin Epidemiol 2002 55 184 91 10.1016/s0895-4356(01)00433-4 11809357
26 Quan H Sundararajan V Halfon P et al Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data Med Care 2005 43 1130 9 10.1097/01.mlr.0000182534.19832.83 16224307
27 Alberta coding access targets for surgery (ACATS) codes: alberta health services n.d. Available https://www.albertahealthservices.ca/scns/Page12961.aspx
28 Harrell F Regression modeling strategies. 6.8-0 ed: R package 2023
29 Wickham H ggplot2: Elegant graphics for data analysis Cham: Springer 2016 Available http://link.springer.com/10.1007/978-3-319-24277-4
30 COVID tracker: centre for health informatics n.d. Available https://covid-tracker.chi-csm.ca/
31 Ibadin S Brindle M Wasylak T et al Surgical care in Canada during COVID-19: an environmental scan Int J Health Care Policy 2023 10.34172/ijhpm.2023.8007
32 Malekinejad M Horvath H Snyder H et al The discordance between evidence and health policy in the United States: the science of translational research and the critical role of diverse stakeholders Health Res Policy Syst 2018 16 81 10.1186/s12961-018-0336-7 30115085
33 Orton L Lloyd-Williams F Taylor-Robinson D et al The use of research evidence in public health decision making processes: systematic review PLoS One 2011 6 e21704 10.1371/journal.pone.0021704 21818262
34 Tolone S Gambardella C Brusciano L et al Telephonic triage before surgical ward admission and telemedicine during COVID-19 outbreak in Italy. Effective and easy procedures to reduce in-hospital positivity Int J Surg 2020 78 123 5 10.1016/j.ijsu.2020.04.060 32360932
35 Zhen L Lin T Zhao ML et al Management strategy for the resumption of regular diagnosis and treatment in gastrointestinal surgery department during the outbreak of coronavirus disease 2019 (COVID-19) Zhonghua Wei Chang Wai Ke Za Zhi 2020 23 321 6 10.3760/cma.j.issn.1671-0274.2020-0316-00146 32306596
36 Oliver K Lorenc T Innvær S New directions in evidence-based policy research: a critical analysis of the literature Health Res Policy Syst 2014 12 34 10.1186/1478-4505-12-34 25023520
37 McIsaac DI Abdulla K Yang H et al Association of delay of urgent or emergency surgery with mortality and use of health care resources: a propensity score–matched observational cohort study CMAJ 2017 189 E905 12 10.1503/cmaj.160576 28694308
38 Pincus D Ravi B Wasserstein D et al Association between wait time and 30-day mortality in adults undergoing hip fracture surgery JAMA 2017 318 1994 2003 10.1001/jama.2017.17606 29183076
39 Appleby J What is happening to non-covid deaths? BMJ 2020 369 m1607 10.1136/bmj.m1607 32332059
40 Beesoon S Joffe MA Bakal J et al Excess deaths during COVID-19 pandemic in Alberta, Canada Int J Infect Dis 2022 116 S23 10.1016/j.ijid.2021.12.055
41 Tam DY Naimark D Sander B et al COVID-19: predicting consequences of curtailing outpatient scheduled cardiac procedures in the face of COVID healthcare resource needs in Ontario 2020
42 Kulkarni GS Urbach DR Austin PC et al Longer wait times increase overall mortality in patients with bladder cancer J Urol 2009 182 1318 24 10.1016/j.juro.2009.06.041 19683272
43 Ackerman IN Graves SE Wicks IP et al Severely compromised quality of life in women and those of lower socioeconomic status waiting for joint replacement surgery Arthritis Rheum 2005 53 653 8 10.1002/art.21439 16208653
44 Desmeules F Dionne CE Belzile E et al Waiting for total knee replacement surgery: factors associated with pain, stiffness, function and quality of life BMC Musculoskelet Disord 2009 10 52 10.1186/1471-2474-10-52 19457252
45 Malik AT Alexander JH Li DD et al What are the costs of hip osteoarthritis in the year prior to a total hip arthroplasty? J Arthroplasty 2020 35 313 7 10.1016/j.arth.2019.09.020 31601455
46 Mascarenhas R The Manitoba arthroplasty waiting list: impact on health-related quality of life and initiatives to remedy the problem J Eval Clin Pract 2009 15 208 11 10.1111/j.1365-2753.2008.00985.x 19239604
47 Nikolova S Harrison M Sutton M The impact of waiting time on health gains from surgery: evidence from a national patient-reported outcome dataset Health Econ 2016 25 955 68 10.1002/hec.3195 26013773
48 Sommer JL Jacobsohn E El-Gabalawy R Impacts of elective surgical cancellations and postponements in Canada Can J Anaesth 2021 68 315 23 10.1007/s12630-020-01824-z 33085061
49 Jaworska N Schalm E Kersen J et al The impact of delayed nonurgent surgery during the COVID-19 pandemic on surgeons in Alberta: a qualitative interview study CMAJ Open 2023 11 E587 96 10.9778/cmajo.20220188
50 Moynihan R Sanders S Michaleff ZA et al Impact of COVID-19 pandemic on utilisation of healthcare services: a systematic review BMJ Open 2021 11 e045343 10.1136/bmjopen-2020-045343
51 Soares P Leite A Esteves S et al Factors associated with the patient’s decision to avoid healthcare during the COVID-19 pandemic Int J Environ Res Public Health 2021 18 13239 10.3390/ijerph182413239 34948847
52 Arnetz BB Goetz C vanSchagen J et al Patient-reported factors associated with avoidance of in-person care during the COVID-19 pandemic: results from a national survey PLOS ONE 2022 17 e0272609 10.1371/journal.pone.0272609 35930581
53 Habbous S Lambrinos A Petersen S et al The effect of the COVID-19 pandemic on hospital admissions and outpatient visits in Ontario, Canada Ann Thorac Med 2023 18 70 8 10.4103/atm.atm_376_22 37323374
54 Alshahrani MS Alfaraj D AlHumaid J et al Prevalence, causes, and adverse clinical impact of delayed presentation of non-COVID-19-related emergencies during the covid-19 pandemic: findings from a multicenter observational study Int J Environ Res Public Health 2022 19 9818 10.3390/ijerph19169818 36011457
55 Maringe C Spicer J Morris M et al The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study Lancet Oncol 2020 21 1023 34 10.1016/S1470-2045(20)30388-0 32702310
